Evidence map›Paper›PMID 25593231›Full record

ReviewThe Journal of rheumatology2015

The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive.

Eric W Orlowsky, Virginia Byers Kraus

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of rheumatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 3 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 3 syntheses or guidelines pooled it, 294 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Identification of Antibodies to Chondrocyte and Synoviocyte Antigens in Equine Osteoarthritis.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric W OrlowskyFrom the Department of Medicine, Duke Molecular Physiology Institute, and the Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.E.W. Orlowsky, MD, Postdoctoral Fellow, Division of Rheumatology, Duke University School of Medicine; V.B. Kraus, MD, PhD, Professor of Medicine, Department of Medicine, Duke Molecular Physiology Institute, and Division of Rheumatology, Duke University School of Medicine.
Virginia Byers KrausFrom the Department of Medicine, Duke Molecular Physiology Institute, and the Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.E.W. Orlowsky, MD, Postdoctoral Fellow, Division of Rheumatology, Duke University School of Medicine; V.B. Kraus, MD, PhD, Professor of Medicine, Department of Medicine, Duke Molecular Physiology Institute, and Division of Rheumatology, Duke University School of Medicine. vbk@duke.edu.
Duke University · US

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
TRAINING PROGRAM IN INFLAMMATORY AND IMMUNOLOGICALT32AI007217 · NIAID · DUKE UNIVERSITY · PI PISETSKY, DAVID STEPHEN · 1985 to 2015
$3.3M
NIAID NIH HHS 5T32AI007217-30NIAID NIH HHS T32 AI007217NIAMS NIH HHS P01 AR050245NIA NIH HHS 5P30 AG028716NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

Although osteoarthritis (OA) has existed since the dawn of humanity, its pathogenesis remains poorly understood. OA is no longer considered a "wear and tear" condition but rather one driven by proteases where chronic low-grade inflammation may play a role in perpetuating proteolytic activity. While multiple factors are likely active in this process, recent evidence has implicated the innate immune system, the older or more primitive part of the body's immune defense mechanisms. The roles of some of the components of the innate immune system have been tested in OA models in vivo including the roles of synovial macrophages and the complement system. This review is a selective overview of a large and evolving field. Insights into these mechanisms might inform our ability to identify patient subsets and give hope for the advent of novel OA therapies.

Indexed as

Immunity, InnateHumansInflammationOsteoarthritisSynovial MembraneCOMPLEMENTINNATE IMMUNITYMACROPHAGESOSTEOARTHRITIS

Identifiers

PMID25593231
PMCPMC4465583
OpenAlexW2144995521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.